探讨乳酰化相关基因在脓毒症中的预后和诊断价值。
Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis.
机构信息
Department of Emergency Medicine, The Affiliated Hospital, Southwest Medical University, 25 Taiping Street, JiangYang District, Luzhou, Sichuan, China.
The Fourth People's Hospital of Zigong, Southwest Medical University, ZiGong, Si Chuan, China.
出版信息
Sci Rep. 2024 Oct 4;14(1):23130. doi: 10.1038/s41598-024-74040-0.
The discovery of Lactylation may pave the way for novel approaches to investigating sepsis. This study focused on the prognostic and diagnostic significance of lactylated genes in sepsis. RNA sequencing was performed on blood samples from 20 sepsis patients and 10 healthy individuals at Southwest Medical University in Luzhou, Sichuan, China. Genes associated with sepsis were identified through analysis of RNA sequencing data. Afterward, the genes that were expressed differently were compared with the lactylation genes, resulting in the identification of 55 lactylation genes linked to sepsis. The overlapping genes underwent analysis using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Protein-Protein Network Interactions were used to screen for the core genes. The datasets GSE65682, GSE69528, GSE54514, GSE63042, and GSE95233 were obtained from the GEO database to validate core genes. Survival analysis evaluated the predictive significance of central genes in sepsis, while Receiver Operating Characteristic (ROC) Curve analysis was employed to establish the diagnostic value of genes. Additionally, a meta-analysis was conducted to confirm the precision of RNA-seq data. We obtained five peripheral blood samples, including two from healthy individuals, one from a patient with systemic inflammatory response syndrome (SIRS), and two from patients with sepsis. These samples were used to identify the specific location of core genes using 10×single-cell sequencing. High-throughput sequencing and bioinformatics techniques identified two lactylation-related genes (S100A11 and CCNA2) associated with sepsis. Survival analysis indicated that septic patients with reduced levels of S100A11 had a decreased 28-day survival rate compared to those with elevated levels. Conversely, individuals exhibiting decreased CCNA2 levels demonstrated a greater likelihood of surviving for 28 days than those in the high expression category, indicating a favorable association with survival rates among sepsis patients (P < 0.05). Both genes showed high sensitivity and specificity based on the ROC curve, with AUC values of 0.961 for S100A11 and 0.890 for CCNA2. The meta-analysis revealed that S100A11 exhibited high levels of expression in the sepsis survivors, whereas it displayed low levels of expression in the non-survivors; on the other hand, CCNA2 demonstrated low expression in the sepsis survivors and high expression in the non-survivors (P < 0.05). Single-cell RNA sequencing ultimately showed that monocyte macrophages, T cells, and B cells exhibited high expression levels of the crucial genes associated with sepsis-induced lactylation. In conclusion, the lactylation genes S100A11 and CCNA2 are strongly linked to sepsis and could be valuable markers for diagnosing, predicting outcomes, and providing guidance for sepsis.
乳酰化的发现可能为研究败血症开辟新途径。本研究重点探讨了败血症中乳酰化基因的预后和诊断意义。在中国四川泸州西南医科大学采集了 20 名败血症患者和 10 名健康个体的血液样本进行 RNA 测序。通过 RNA 测序数据分析确定与败血症相关的基因。之后,将差异表达的基因与乳酰化基因进行比较,鉴定出与败血症相关的 55 个乳酰化基因。利用基因本体论(GO)和京都基因与基因组百科全书(KEGG)对重叠基因进行分析。利用蛋白质-蛋白质网络互作筛选核心基因。从 GEO 数据库中获取数据集 GSE65682、GSE69528、GSE54514、GSE63042 和 GSE95233,以验证核心基因。生存分析评估了核心基因在败血症中的预测意义,而接收者操作特征(ROC)曲线分析则用于建立基因的诊断价值。此外,还进行了荟萃分析以确认 RNA-seq 数据的准确性。我们获得了五份外周血样本,其中两份来自健康个体,一份来自全身炎症反应综合征(SIRS)患者,两份来自败血症患者。使用 10×单细胞测序确定核心基因的特定位置。高通量测序和生物信息学技术鉴定出与败血症相关的两个乳酰化相关基因(S100A11 和 CCNA2)。生存分析表明,与高表达水平的患者相比,S100A11 水平降低的败血症患者 28 天生存率降低。相反,CCNA2 水平降低的患者 28 天生存率高于高表达水平的患者,表明其与败血症患者的生存率呈正相关(P<0.05)。基于 ROC 曲线,两个基因均显示出高灵敏度和特异性,S100A11 的 AUC 值为 0.961,CCNA2 的 AUC 值为 0.890。荟萃分析显示,S100A11 在败血症幸存者中表达水平较高,而非幸存者中表达水平较低;另一方面,CCNA2 在败血症幸存者中表达水平较低,而非幸存者中表达水平较高(P<0.05)。单细胞 RNA 测序最终显示,单核细胞巨噬细胞、T 细胞和 B 细胞中与败血症诱导的乳酰化相关的关键基因表达水平较高。总之,乳酰化基因 S100A11 和 CCNA2 与败血症密切相关,可能是诊断、预测预后和指导败血症治疗的有价值的标志物。